FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2005637259> ?p ?o ?g. }

• W2005637259 endingPage "178" @default.
• W2005637259 startingPage "167" @default.
• W2005637259 abstract "Recent double-blind placebo-controlled trials for perennial allergic rhinitis have all clearly shown the efficacy of immunotherapy. Although several mechanisms for the clinical efficacy of immunotherapy have been proposed, the exact mechanisms related to the clinical effect still remain unclear. Since immunotherapy is a form of systemic treatment and its clinical benefit is likely to be, at least in part, a consequence of its systemic effects on different phases of immunological events, our study focused exclusively on several immunological parameters in serum. A total of 47 patients with perennial allergic rhinitis due to Dermatophagoides farinae enrolled in this prospective study. Venous blood was collected for determination of specific immunoglobulin (Ig)E, specific IgG4, soluble interleukin-2 receptor (IL-2R), interleukin-4 (IL-4), soluble intercellular adhesion molecule-1 (ICAM-1) and soluble vascular cell adhesion molecule-1 (VCAM-1), six times from 20 untreated patients and 27 patients on immunotherapy, at enrolment, and 1, 2, 3, 5, and 10 years after enrollment. No specific IgE, IgG4, soluble IL-2R, IL-4 and soluble ICAM-1 levels changed significantly for a span of 10 years in the untreated patients. By contrast, immunotherapy affected serum levels of specific IgE, specific IgG4, soluble IL-2R, IL-4 and soluble ICAM-1, but not of soluble VCAM-1. The rates of increase in specific IgG4 and the rates of decrease in soluble IL-2R were correlated with the rates of decrease in symptom scores during the first 3 years, but not 5 and 10 years after the course of immunotherapy. On the other hand, the rates of decrease in specific IgE, IL-4 and soluble ICAM-1 were significantly correlated with the rates of decrease in symptom scores at 5 and 10 years, but not during the first 3 years. Each immunological modulation by immunotherapy was likely to be involved in the working mechanism related to clinical efficacy at different phases of immunotherapy." @default.
• W2005637259 created "2016-06-24" @default.
• W2005637259 creator A5016525421 @default.
• W2005637259 creator A5024892252 @default.
• W2005637259 creator A5025012086 @default.
• W2005637259 creator A5037470197 @default.
• W2005637259 creator A5060049548 @default.
• W2005637259 creator A5081640615 @default.
• W2005637259 creator A5081852652 @default.
• W2005637259 creator A5084068835 @default.
• W2005637259 creator A5084150868 @default.
• W2005637259 date "1998-02-01" @default.
• W2005637259 modified "2023-10-16" @default.
• W2005637259 title "Ten‐Year Follow‐Up Study of Allergen‐Specific Immunoglobulin E and Immunoglobulin G4, Soluble Interleukin‐2 Receptor, Interleukin‐4, Soluble Intercellular Adhesion Molecule‐1 and Soluble Vascular Cell Adhesion Molecule‐1 in Serum of Patients on Immunotherapy for Perennial Allergic Rhinitis" @default.
• W2005637259 cites W1967550229 @default.
• W2005637259 cites W1969912242 @default.
• W2005637259 cites W1971990400 @default.
• W2005637259 cites W1973485202 @default.
• W2005637259 cites W1979225325 @default.
• W2005637259 cites W1980700255 @default.
• W2005637259 cites W1982217075 @default.
• W2005637259 cites W2000406728 @default.
• W2005637259 cites W2002549953 @default.
• W2005637259 cites W2015037737 @default.
• W2005637259 cites W2024937157 @default.
• W2005637259 cites W2030942529 @default.
• W2005637259 cites W2032260549 @default.
• W2005637259 cites W2032732214 @default.
• W2005637259 cites W2035414461 @default.
• W2005637259 cites W2038197555 @default.
• W2005637259 cites W2043860869 @default.
• W2005637259 cites W2085213750 @default.
• W2005637259 cites W2089740140 @default.
• W2005637259 cites W2093238448 @default.
• W2005637259 cites W2124859060 @default.
• W2005637259 cites W2126681179 @default.
• W2005637259 cites W2157953677 @default.
• W2005637259 cites W2160572043 @default.
• W2005637259 cites W2167205739 @default.
• W2005637259 cites W2169302097 @default.
• W2005637259 cites W2170079873 @default.
• W2005637259 cites W2317050597 @default.
• W2005637259 cites W2319396943 @default.
• W2005637259 cites W2323854595 @default.
• W2005637259 cites W2411923273 @default.
• W2005637259 cites W4252835308 @default.
• W2005637259 doi "https://doi.org/10.1046/j.1365-3083.1998.00278.x" @default.
• W2005637259 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9496694" @default.
• W2005637259 hasPublicationYear "1998" @default.
• W2005637259 type Work @default.
• W2005637259 sameAs 2005637259 @default.
• W2005637259 citedByCount "15" @default.
• W2005637259 countsByYear W20056372592016 @default.
• W2005637259 crossrefType "journal-article" @default.
• W2005637259 hasAuthorship W2005637259A5016525421 @default.
• W2005637259 hasAuthorship W2005637259A5024892252 @default.
• W2005637259 hasAuthorship W2005637259A5025012086 @default.
• W2005637259 hasAuthorship W2005637259A5037470197 @default.
• W2005637259 hasAuthorship W2005637259A5060049548 @default.
• W2005637259 hasAuthorship W2005637259A5081640615 @default.
• W2005637259 hasAuthorship W2005637259A5081852652 @default.
• W2005637259 hasAuthorship W2005637259A5084068835 @default.
• W2005637259 hasAuthorship W2005637259A5084150868 @default.
• W2005637259 hasBestOaLocation W20056372591 @default.
• W2005637259 hasConcept C126322002 @default.
• W2005637259 hasConcept C141105273 @default.
• W2005637259 hasConcept C159654299 @default.
• W2005637259 hasConcept C16224149 @default.
• W2005637259 hasConcept C170493617 @default.
• W2005637259 hasConcept C203014093 @default.
• W2005637259 hasConcept C207480886 @default.
• W2005637259 hasConcept C2777371288 @default.
• W2005637259 hasConcept C2777701055 @default.
• W2005637259 hasConcept C2778690821 @default.
• W2005637259 hasConcept C2909375385 @default.
• W2005637259 hasConcept C71924100 @default.
• W2005637259 hasConcept C8891405 @default.
• W2005637259 hasConceptScore W2005637259C126322002 @default.
• W2005637259 hasConceptScore W2005637259C141105273 @default.
• W2005637259 hasConceptScore W2005637259C159654299 @default.
• W2005637259 hasConceptScore W2005637259C16224149 @default.
• W2005637259 hasConceptScore W2005637259C170493617 @default.
• W2005637259 hasConceptScore W2005637259C203014093 @default.
• W2005637259 hasConceptScore W2005637259C207480886 @default.
• W2005637259 hasConceptScore W2005637259C2777371288 @default.
• W2005637259 hasConceptScore W2005637259C2777701055 @default.
• W2005637259 hasConceptScore W2005637259C2778690821 @default.
• W2005637259 hasConceptScore W2005637259C2909375385 @default.
• W2005637259 hasConceptScore W2005637259C71924100 @default.
• W2005637259 hasConceptScore W2005637259C8891405 @default.
• W2005637259 hasIssue "2" @default.
• W2005637259 hasLocation W20056372591 @default.
• W2005637259 hasLocation W20056372592 @default.
• W2005637259 hasOpenAccess W2005637259 @default.
• W2005637259 hasPrimaryLocation W20056372591 @default.
• W2005637259 hasRelatedWork W1571696686 @default.
• W2005637259 hasRelatedWork W1994983944 @default.
• W2005637259 hasRelatedWork W2000438593 @default.

• next